Chrystal U. Louis's most recent trade in Tscan Therapeutics Inc was a trade of 400,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tscan Therapeutics Inc | Chrystal U. Louis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Chrystal U. Louis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 380,000 | 380,000 | - | - | Stock Option (Right to Buy) |